Search Results for: probiotics
Role of probiotics in the management of gastrointestinal disorders
Find out if probiotics are recommended, and if so what strains, for specific GI conditions. This guideline covers C. difficile infection, adults and children on antibiotic treatment, Crohn’s disease, ulcerative colitis, pouchitis, irritable bowel syndrome (IBS), acute infectious gastroenteritis, and preterm/low-birth-weight infants.
Management of pouchitis and inflammatory pouch disorders
1. In patients with ulcerative colitis who undergo IPAA, the AGA makes no recommendation in favor of, or against, the use of probiotics for primary prevention of pouchitis. 2. In patients with ulcerative colitis who undergo IPAA, the AGA suggests against using antibiotics for the primary prevention of pouchitis. 3. In patients with ulcerative […]
Gut Microbiome
[…] news, resources & education Microbiome Minute Welcome to a new series where experts break down the most interesting research developments in the space with 1-minute summaries. Nutrition and probiotics These resources address our current understanding of the interplay between nutrition and the gut microbiome, and what it all may mean for human health and disease. […]
First comprehensive medical guideline on management of pouchitis released
[…] with ulcerative colitis who undergo proctocolectomy with ileal pouch-anal anastomosis, also known as IPAA or J-pouch. AGA suggests initial treatment of pouchitis with antibiotics. Treatment with multi-strain probiotics following an antibiotic course is suggested for preventing recurrent pouchitis. AGA suggests cyclical or near continuous antibiotic therapy to treat pouchitis that responds to antibiotics but […]
AGA Center for Gut Microbiome Research & Education
[…] researchers, nutritionists, and dietitians from around the globe in a dynamic learning environment. Learn more and register Major programs FMT and Other Gut Microbial Therapies National Registry Probiotics clinical guideline The latest on the gut microbiome Visit the microbiome area of our website, your hub for everything gut microbiome including current research, upcoming events […]
Irritable bowel syndrome toolkit
[…] updates to help clinicians answer key questions related to the care of people with irritable bowel syndrome. The role of diet in IBS Should IBS patients take probiotics? How to choose lab tests for IBS-D View more clinical guidance For physicians Education AGA University helps physicians learn about how to care for people with […]
Evaluation and management of belching, abdominal bloating and distention
[…] out a pelvic floor disorder. 9. When dietary modifications are needed (e.g., low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet), a gastroenterology dietitian should preferably monitor treatment. 10. Probiotics should not be used to treat abdominal bloating and distention. 11. Biofeedback therapy may be effective for bloating and distention when a pelvic floor disorder is […]
Management of refractory helicobacter pylori infection
[…] with patient demographic and clinical factors (including prior non-H. pylori antibiotic exposure) is important. Aggregated data should be made publicly available to guide local selection of H. pylori eradication therapy. 12. Proposed adjunctive therapies, including probiotics, are of unproven benefit as treatment for refractory H. pylori infection, and thus, their use should be considered experimental.
Management of Crohn’s disease after surgical resection
[…] (anti-TNF) therapy and/or thiopurines over other agents. 3. In patients with surgically induced remission of Crohn’s disease, AGA suggests against using mesalamine (or other 5-aminosalicylates), budesonide or probiotics. 4. In patients with surgically induced remission of Crohn’s disease receiving pharmacological prophylaxis, AGA suggests postoperative endoscopic monitoring at 6 to 12 months after surgical resection […]
Management of acute diverticulitis
[…] use of nonaspirin NSAIDs if possible. 8. AGA recommends against the use of mesalamine after acute uncomplicated diverticulitis. 9. AGA suggests against the use of rifaximin after acute uncomplicated diverticulitis. 10. AGA suggests against the use of probiotics after acute uncomplicated diverticulitis. 11. AGA suggests advising patients with diverticular disease to consider vigorous physical activity.